Ingenuity® Pathway Analysis (IPA®)
Ingenuity® Pathway Analysis (IPA®) is a powerful analysis and search tool that uncovers the significance of ‘omics data and identifies new targets or candidate biomarkers within the context of biological systems. IPA has broadly been adopted by the life science research community and is cited in thousands of articles for the analysis, integration, and interpretation of data derived from ‘omics experiments, such as RNA-seq, small RNA-seq, microarrays including miRNA and SNP, metabolomics, proteomics, and small scale experiments.
With it’s many features, IPA allows you to quickly understand and visualize your data.
UMass Medical IT Department facilitated a license share program that involved a limited number of seats to be shared concurrently between two site licenses. If you missed the opportunity to particpate in the 2017 - 2018 licenses, you can contact Byron Deane to participate in the next renewal or to see if there is an open seat for the current license term. Byron.Deane@umassmed.edu The cost of a seat in the current term is just under $2,000.
If you are participating in the UMMS IPA Concurrent License share program and have an active account, you can schedule your time using the QIAGEN IPA scheduler tool. Please schedule your time in 30, 60, 90 or 120 minute intervals. To be fair to all of the participants, we are limiting the durations to a 2-hour maximum. After monitoring usage for a few weeks, we will re-assess these scheduling limitations so that all of the participants are able to access the software equally.